Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Exam 1: NU664D/ NU 664D (NEW 2025/ 2026 Update) Guide | 100% Correct- Regis, Exams of Nursing

Exam 1: NU664D/ NU 664D (NEW 2025/ 2026 Update) Guide | 100% Correct- Regis

Typology: Exams

2024/2025

Available from 07/03/2025

Ace_it.
Ace_it. šŸ‡ŗšŸ‡ø

568 documents

1 / 32

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Examl 1:l NU664D/l NUl 664Dl (NEWl 2025/l
2026l Update)l Primaryl Carel Adultl
Womanl Il Guide|l Questionsl &l Answers|l
Gradel A|l 100%l Correctl (Verifiedl
Solutions)-l Regis
QUESTION
Whatl tol dol ifl al vaginall ringl fallsl out
Answer:
ifl lessl thanl 3l hours,l canl rinsel offl andl replace
ifl itl hasl beenl greaterl thanl 3l hours:
-ifl itl isl withinl 2l weekl ofl thel nextl cycle,l re-insertl thel ringl andl usel backl upl
contraceptionl for.l 7days
-ifl itl hasl fallenl outl withinl weekl 3l ofl thel cycle,l canl insertl al brandl newl ringl insteadl
butl stilll needl backupl forl 7l days
QUESTION
howl tol usel vaginall ringl (4l steps)
Answer:
1.l insertl intol vaginal b/wl daysl 1-5l ofl period
2.l wearl forl 3l wks
3.l removel forl 1l wk
4.l replacel withl newl ring
QUESTION
whatl typesl ofl patientsl isl al POPl goodl for?
Answer:
-patientsl whol cannotl takel estrogenl duel tol contraindications
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20

Partial preview of the text

Download Exam 1: NU664D/ NU 664D (NEW 2025/ 2026 Update) Guide | 100% Correct- Regis and more Exams Nursing in PDF only on Docsity!

Exam l 1: l NU664D/ l NU l 664 D l (NEW l 2025/ l

2026 l Update) l Primary l Care l Adult l

Woman l I l Guide| l Questions l & l Answers| l

Grade l A| l 100% l Correct l (Verified l

Solutions)- l Regis

QUESTION

Whatl tol dol ifl al vaginall ringl fallsl out Answer: ifl lessl thanl 3 l hours,l canl rinsel offl andl replace ifl itl hasl beenl greaterl thanl 3 l hours:

  • ifl itl isl withinl 2 l weekl ofl thel nextl cycle,l re-insertl thel ringl andl usel backl upl contraceptionl for.l 7days
  • ifl itl hasl fallenl outl withinl weekl 3 l ofl thel cycle,l canl insertl al brandl newl ringl insteadl butl stilll needl backupl forl 7 l days

QUESTION

howl tol usel vaginall ringl (4l steps) Answer: 1.l insertl intol vaginal b/wl daysl 1 - 5 l ofl period 2.l wearl forl 3 l wks 3.l removel forl 1 l wk 4.l replacel withl newl ring

QUESTION

whatl typesl ofl patientsl isl al POPl goodl for? Answer:

  • patientsl whol cannotl takel estrogenl duel tol contraindications
  • lactatingl women

QUESTION

Intermittentl Asthma Answer:

  • <2l days/weekl ofl symptoms
  • <2l days/monthl ofl symptoms
  • FEVl >80%

QUESTION

Mildl intermittentl asthma Answer:

  • 2l days/weekl ofl symptoms,l butl lessl thanl onel dayl al week

  • 2l days/monthl ofl symptoms

  • FEVl >80%

QUESTION

moderatel persistentl asthma Answer:

  • dailyl symptoms
  • nocturnall symptomsl >1l timel perl month
  • Exacerbationsl 2xl daily
  • Exacerbationsl affectl ADLsl
  • FEVl >60l butl <80%

QUESTION

severel persistentl asthma Answer:

  • dailyl S/Sl continuous
  • Nocturnall s/sl frequentl
  • Exacerbationsl frequent
  • Exacerbationsl affectl andl limitl ADLs
  • FEVl <60%

FEV1/FVCl valuel ofl <0.

QUESTION

GOLDl 1 Answer:

  • Mildl severity
  • FEV1l 80%l orl greater

QUESTION

GOLDl 2 Answer:

  • moderatel severity
  • FEV1l 50 - 79%

QUESTION

GOLDl 3 Answer:

  • Severe
  • FEV1l 30 - 49%

QUESTION

GOLDl 4 Answer:

  • veryl severe
  • FEVl <30%

QUESTION

Treatmentl forl COPDl classl A Answer: bronchodilatorl only

QUESTION

Treatmentl forl COPDl B Answer: LABAl orl LAMA

QUESTION

Treatmentl forl COPDl C Answer: LAMA

QUESTION

Treatmentl forl COPDl D Answer: optionl b/w

  • LAMA
  • LAMAl +l LABA
  • ICSl +l LABA

QUESTION

POPl (minipill)l MOA? Answer:

  • inhibitl ovulation
  • thickenl cervicall mucus
  • causesl thel endometriuml tol thin/atrophy
  • alteredl tuball transport,l contractility,l histology

QUESTION

POPl benefits Answer:

Checkl colorl andl consistencyl tol determinel fertilel times

  • aroundl ovulation,l mucusl isl abundant,l clear,l slippery,l stretchable
  • thisl isl thel mostl dangerousl time,l sperml canl livel upl tol 5 l days
  • dryl daysl withl nol cervixl dischargel isl thel onlyl safel time

QUESTION

Emergencyl Contraceptives Answer: 1.l Levonorgestrel 2.l Ulipristall (rxl only)l - l Ella,l morel effectivel thanl levonorgestrel 3.l Copperl IUD

QUESTION

firstl linel treatmentl hypothyroidism Answer: levothyroxine startingl dosel ofl 1.6mcg/kg/day

QUESTION

s/sl ofl hypothyroidism Answer:

  • Fatigue
  • Weightl gain
  • Constipation
  • Depression
  • Coldl intolerance
  • Decreasedl metabolism
  • Dryl skinl andl hair
  • Brittlel nails
  • Changel inl menstruall cycle

QUESTION

firstl linel treatmentl forl hyperthyroidism

Answer: methimazolel (MMI)

QUESTION

S/Sl ofl hyperthyroidism Answer:

  • Anxiety
  • Palpitations
  • Heatl intolerance
  • Jitteriness
  • Diarrhea
  • Goiter
  • Oilyl skinl andl hair
  • Exophthalmosl
  • Lidl lag

QUESTION

riskl factorsl forl thyroidl nodule Answer:

  • ETOHl use
  • Obesity
  • Smoking
  • Uterinel fibroids
  • Age

QUESTION

hypothyroidisml labs Answer: Lowl FT4l andl T3,l highl TSH

QUESTION

hyperthyroidisml labs

Normall ferritinl levels Answer: Female:l 24 - 307 l ng/mL Male:l 24 - 336 l ng/mL

QUESTION

normall hematocritl levels Answer: Male:l 42 - 50% Female:l 37 - 47%

QUESTION

Normall MCVl range Answer: 80 - 98

QUESTION

Normall reticulocytel count Answer: 0.5-1.5%l ofl RBCs

QUESTION

normall RBC Answer: 4 - 6 l million

QUESTION

normall platelets Answer:

QUESTION

normall RDW Answer: 9.0-14.5%

QUESTION

normall TIBCl levels Answer: 250 - 310 l mcg/dL

QUESTION

Riskl factorsl forl breastl cancer Answer:

  • smoking
  • obesity
  • alcoholl use
  • increasingl age
  • familyl historyl ofl breastl orl ovarianl cancer
  • Ashkenazil Jewishl descent
  • youngerl agel atl menarche
  • olderl agel atl firstl birth

QUESTION

riskl factorsl forl cervicall cancer Answer:

  • infectionl withl HPV
  • highl riskl sexuall behaviors,l multiplel partners
  • smoking
  • <18l y.o.l firstl timel havingl sex
  • personall hxl ofl cervicall dysplasial orl dysplasial ofl thel vagina
  • Immunocompromised

lowl gradel squamousl intraepitheliall lesion

  • oftenl encompassesl HPV,l mildl dysplasia
  • typicallyl resolvesl onl it'sl own
  • CIN

QUESTION

HSIL

Answer: high-gradel squamousl intraepitheliall lesion

  • morel severel dysplasia
  • demonstratesl CIN2l orl CIN3,l orl evenl carcinomal inl situ
  • CANl LEADl TOl CERVICALl CANCER

QUESTION

copperl IUDl MOA Answer:

  • IUDl placementl (foreignl body)l leadsl tol inflammatoryl processl thatl isl toxicl tol sperm
  • copperl enhancesl thel cytotoxicl environmentl forl sperml tol livel in
  • impairedl sperml viability,l migration

QUESTION

copperl IUDl contraindications Answer: IUDl inl general

  • cervicall dysplasia/cancer
  • cervicitis
  • currentl infectionl w/l gonorrhea,l chlamydial
  • distortedl uterinel cavity
  • currentl PID
  • pregnancy
  • unexplainedl vaginall bleeding COPPER
  • severel thrombocytopenia

QUESTION

LNG-IUDl advantages Answer:

  • l decreasedl ectopicl risk
  • l decreasedl endometriosisl pain
  • decreasedl dysmenorrhea
  • longl lasting
  • reversible
  • veryl effectivel --reducedl riskl forl cervical,l endometrial,l andl ovarianl cancers

QUESTION

LNGl IUDl complications Answer:

  • l PIDl riskl transientlyl increasedl afterl insertionl -->l highestl inl 1stl 20 l daysl
  • l uterinel perforationl
  • devicel expulsionl (withinl firstl year)

QUESTION

copperl IUDl complications Answer:

  • l PIDl
  • l uterinel perforationl
  • l expulsion

QUESTION

Copperl IUDl advantages Answer:

  • l longl term/longl acting
  • l reversible
  • l goodl forl thosel thatl can'tl orl dol notl wantl tol usel hormonesl

QUESTION

DMPAl advantages Answer:

  • Nol estrogen
  • lightl mensesl orl amenorrhea
  • fewl systemicl symptoms
  • improvel menstruall symptoms,l dysmenorrhea

QUESTION

DMPAl sidel effects Answer:

  • WEIGHTl GAIN
  • cannotl d/cl immediately
  • menstruall irregularitiesl (unscheduledl bleeding,l amenorrhea)
  • headache
  • moodl chxl (espl inl ptsl w/l hxl ofl depression)

QUESTION

DMPAl complications Answer: REDUCTIONl OFl BONEl DENSITYl AFTERl 2 l YEARSl OFl USE-l BLACKl BOX PTl ADVISEDl TOl INCREASEl CALCIUM,l VITAMINl D,l EXERCISE,l AVOIDl CIGARETTES

QUESTION

DMPAl frequency Answer: Everyl 12 l weeks'

QUESTION

Missedl DMPA Answer:

  • therel isl al 2 l weekl gracel period,l thereforel ifl withinl thatl periodl canl justl receivel nextl dose
  • ifl >15l weeks:l rulel outl pregnancy,l administerl nextl dose,l usel back-upl contraceptionl forl 7 l days

QUESTION

Spermicidesl MOA Answer: reducel sperml motilityl andl activity

QUESTION

howl longl tol leavel spermicidesl postl coitus Answer: atl leastl 6 l hours

QUESTION

howl earlyl shouldl youl placel spermicidesl beforel sex Answer: 10 - 15 l min

QUESTION

vaginall sponge,l cervicall cap,l diaphragml MOA Answer:

  • barrierl forl sperml tol reachl thel cervix
  • requiresl usel ofl spermicidesl :l thereforel alsol killl andl decreasel functionl ofl sperm

QUESTION

QUESTION

howl longl shouldl al cervicall capl bel keptl inl place Answer: mustl keepl inl placel minimuml 6 - 8 l hrsl mustl reapplyl spermicidel everyl 6 l hoursl ifl youl continuel tol havel sex

QUESTION

MOAl ofl combinedl contraceptives Answer:

  • l Suppressesl FSHl &l LHl
  • l Progesteronel suppressesl LHl tol preventl thel mid-cyclel surgel (stopsl ovulation)
  • l Progesteronel alsol thickensl cervicall mucus
  • l Estrogenl suppressesl FSHl tol preventl thel selectionl andl emergencel ofl al dominantl follicle

QUESTION

Howl tol usel contraceptivel patch Answer:

  • applyl al newl patchl (buttocks,l upperl torso,l abdomen)
  • wearl al patchl forl 3 l weeks,l applyingl al newl onel atl thel samel day/timel weeklyl
  • removel thel patchl forl 1 l hormonel freel week

QUESTION

contraindicationsl tol al contraceptivel patch Answer: anyl contraindicationsl ofl eitherl estrogenl orl progesterone

30l BMI

QUESTION

contraindicationsl ofl estrogenl therapy

Answer:

  • historyl ofl DVT
  • hxl ofl uncontrolledl hypertension,l CVl diseasel orl stroke
  • hxl ofl migrainel w/l aura
  • olderl thanl 35 l yearsl andl smokingl >15l cigsl daily
  • liverl disease
  • breastl cancer
  • pregnancy
  • lactationl orl lessl thanl 6 l weekl (21l days)l postpartum
  • diabetesl withl complicationsl (nephropathy,l neuropathy,l retinopathy)

QUESTION

contraindicationsl ofl progesterone Answer:

  • pregnancy
  • knownl orl suspectedl breastl cancer
  • undiagnosedl abnormall uterinel bleeding
  • benignl orl malignantl liverl tumors,l cirrhosis,l acutel liverl disease

QUESTION

Breastl cancerl screening Answer: Thel USPSTFl recommendsl screeningl mammographyl forl women,l withl orl withoutl clinicall breastl examination,l everyl 1 l tol 2 l yearsl forl womenl agel 40 l yearsl andl older

QUESTION

follow-upl forl unsatisfactoryl papl results Answer: returnl forl anotherl papl inl 2 - 4 l months

QUESTION

follow-upl ofl normall papl results